Most Common Arrhythmia: Intra-Atrial Re-Entrant Tachycardia

Share this content:
Most Common Arrhythmia: Intra-Atrial Re-Entrant Tachycardia
Most Common Arrhythmia: Intra-Atrial Re-Entrant Tachycardia

MONDAY, Aug. 14, 2017 (HealthDay News) -- For patients with congenital heart disease and atrial arrhythmias, the most common presenting arrhythmia is intra-atrial re-entrant tachycardia (IART), according to a study published in the Aug. 15 issue of the Journal of the American College of Cardiology.

Fabien Labombarda, M.D., from the Montreal Heart Institute, and colleagues conducted a multicenter cohort study involving 482 patients with congenital heart disease and atrial arrhythmias.

The researchers found that IART was the most common presenting arrhythmia (61.6 percent), followed by atrial fibrillation and focal atrial tachycardia (28.8 and 9.5 percent, respectively). There was an increase in the proportion of arrhythmias due to IART with increasing congenital heart disease complexity (47.2, 62.1, and 67.0 percent, respectively, for simple, moderate, and complex defects). Among those aged ≥50 years, atrial fibrillation increased with age to surpass IART as the most common arrhythmia (51.2 versus 44.2 percent). Independent associations with atrial fibrillation were seen for older age (odds ratio, 1.024 per year) and hypertension (odds ratio, 2.00). The predominant arrhythmia pattern was paroxysmal, persistent, and permanent in 62.3, 28.2, and 9.5 percent during a mean follow-up of 11.3 ± 9.4 years. There was an increase in permanent atrial arrhythmias from 3.1 to 22.6 percent in patients aged <20 years to ≥50 years.

"Atrial fibrillation increases in prevalence and atrial arrhythmias progressively become permanent as the population ages," the authors write.

The study was funded by a grant from Boehringer Ingelheim.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »